He noted significant advancements in operational excellence, customer collaboration, and innovation, including the NovaSeq X transition and new partnerships. Illumina reported Q4 revenue of $1.1 ...
Hosted on MSN1mon
ILMN Stock Set to Gain From Latest Updates to the NovaSeq X SeriesIn addition, the new NovaSeq X 25B 100 and 200-cycle kits are now available under Illumina's brand following the company's acquisition of Fluent. ILMN Stock’s Likely Trend Following the News ...
New NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X, and enable newly released Illumina Single-Cell Prep SAN DIEGO, Jan. 7, 2025 /PRNewswire/ -- Illumina ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow ...
Illumina (NASDAQ: ILMN) shares tumbled 16% this past week as investors reeled from a one-two punch of mixed fourth-quarter and full-year 2024 results, plus the prospect of losing all its revenue ...
Many Illumina systems launch in staggered years but are built in parallel. Universal software allows everyone to work more efficiently and benefit from previous upgrades, improvements, and new ...
He noted significant advancements in operational excellence, customer collaboration, and innovation, including the NovaSeq X transition and new partnerships. Illumina reported Q4 revenue of $1.1 ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell ...
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results